Dcf Advisers, LLC Astrazeneca PLC Transaction History
Dcf Advisers, LLC
- $195 Million
- Q1 2025
A detailed history of Dcf Advisers, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Dcf Advisers, LLC holds 45,800 shares of AZN stock, worth $3.37 Million. This represents 1.72% of its overall portfolio holdings.
Number of Shares
45,800Holding current value
$3.37 Million% of portfolio
1.72%Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,419Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.2 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.99 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.62 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.34 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.3 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...